Cautious optimism: Moderna publishes results from vaccine trials, all 45 subjects produce neutralizing antibodies
By Amit SyalThis week, Moderna, the biotechnology company centered out of Massachusetts, released results from its second phase of vaccine trials for COVID-19. The company partnered with researchers at the National Institute of Allergy and Infectious Diseases to develop the vaccine. Read more